1. Home
  2. CDNA vs COLL Comparison

CDNA vs COLL Comparison

Compare CDNA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$21.86

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$32.83

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
COLL
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
CDNA
COLL
Price
$21.86
$32.83
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$27.60
$51.40
AVG Volume (30 Days)
672.4K
454.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.73
Revenue
$48,324,000.00
$780,567,000.00
Revenue This Year
$16.01
$8.01
Revenue Next Year
$11.31
N/A
P/E Ratio
N/A
$19.13
Revenue Growth
18.93
23.62
52 Week Low
$10.96
$26.35
52 Week High
$23.24
$50.79

Technical Indicators

Market Signals
Indicator
CDNA
COLL
Relative Strength Index (RSI) 64.28 42.03
Support Level $16.63 $31.18
Resistance Level $23.24 $36.22
Average True Range (ATR) 1.39 1.36
MACD 0.36 0.09
Stochastic Oscillator 81.12 27.82

Price Performance

Historical Comparison
CDNA
COLL

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: